BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 14, 2011
View Archived Issues
New muscarinic acetylcholine M1 receptor modulators claimed
Read More
Roche discloses new modulators of metabotropic glutamate mGlu5 receptor
Read More
Novel MK2 inhibitors synthesized at Merck & Co.
Read More
SHARP trial assesses simvastatin/ezetimibe combination in chronic kidney disease
Read More
One-pot approach creates semihollow microgel capsules for simultaneous multidrug delivery
Read More
Peptide P-13 ameliorates experimental otitis media
Read More
Dehydro-alpha-lapachone is natural antiangiogenic product that targets cell adhesion
Read More
Newron Pharmaceuticals submits IND for NW-3509 in schizophrenia
Read More
Biotron begins dosing final patient in phase IIa BIT-225 trial in genotype 1 hepatitis C
Read More
Sanofi and Regeneron report phase IIb data on sarilumab
Read More
Novel PKB inhibitors presented
Read More
Eisai to market and distribute Orion's Fareston and Eldepryl in China
Read More
Treatment begins in Cerulean Pharma's phase II CRLX-101 study in NSCLC
Read More
High-dose EPIAO approved in China to treat chemotherapy-associated anemia
Read More
GE Healthcare presents novel diagnostic imaging agents
Read More
AnaptysBio selects new antibody with potential to treat autoimmune diseases
Read More
FDA accepts sNDA for Dacogen in acute myeloid leukemia
Read More
Novadex presents new agents for HBV and HIV infections
Read More
Istituto Europeo di Oncologia patents new tubulin polymerization inhibitors
Read More
DSMB recommends discontinuation of Stallergenes' phase III trial of Actair
Read More
BioAlliance gives update on Livatag and Clonidine Lauriad
Read More
CMX-001 enters phase II trial in adenoviral disease and receives FDA fast track status
Read More
Teva completes acquisition of Taiyo Pharmaceutical
Read More
Consortium led by Ark Therapeutics receives E.U. Framework Programme 7 Grant
Read More
Watson Pharmaceuticals and Antares sign licensing agreement for Anturol gel in U.S. and Canada
Read More